Early findings of a novel established molecular diagnostic technique for the prediction of malignant transformation in leukoplakia

Molecular Medicine Reports

Volumn 2, Issue 6, 2009, Pages 947-952

  Ries, Jutta ^a   Ponader, Sabine ^a   Mollaoglu, Nur ^a,b   Vairaktaris, Eleftherios ^c   Neukam, Friedrich W ^a   Nkenke, Emeka ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GAZI UNIVERSITY   (Turkey)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Diagnosis; Melanoma associated antigen expression; Oral pre cancerous lesions; Oral squamous cell carcinoma; Real time reverse transcriptase polymerase chain reaction

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 10; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MELANOMA ANTIGEN 6; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DYSPLASIA; FEMALE; FIBROMA; FROZEN SECTION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; INFLAMMATORY INFILTRATE; LEUKOPLAKIA; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; PREDICTION; SQUAMOUS CELL CARCINOMA;

EID: 73649128903     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000197     Document Type: Article

References (24)

1. Hunter KD, Parkinson EK and Harrison PR: Profiling early head and neck cancer. Nat Rev Cancer 5: 127-135, 2005.
2. Scheifele C and Reichart PA: Oral leukoplakia in manifest squamous epithelial carcinoma. A clinical prospective study of 101 patients. Mund Kiefer Gesichtschir 2: 326-330, 1998.
3. Jungbluth AA, Busam KJ, Kolb D, et al: Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 85: 460-465, 2000.
4. Boon T, De Plaen E, Lurquin C, et al: Identification of tumour rejection antigens recognized by T lymphocytes. Cancer Surv 13: 23-37, 1992.
5. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61: 5544-5551, 2001.
6. De Plaen E, Arden K, Traversari C, et al: Structure, chromosomal localization and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369, 1994.
7. Van der Bruggen P, Traversari C, Chomez P, et al: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991.
8. Mollaoglu N, Vairaktaris E, Nkenke E, Neukam FW and Ries J: Expression of MAGE-A12 in oral squamous cell carcinoma. Dis Markers 24: 27-32, 2008.
9. Ries J, Schultze-Mosgau S, Neukam F, Diebel E and Wiltfang J: Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int J Oncol 26: 817-824, 2005.
10. Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW and Nkenke E: Expression of melanoma-associated antigens in oral squamous cell carcinoma. J Oral Pathol Med 37: 88-93, 2008.
11. Eura M, Ogi K, Chikamatsu K, et al: Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas. Int J Cancer 64: 304-308, 1995.
12. Park JW, Kwon TK, Kim IH, et al: A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods 266: 79-86, 2002.
13. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
14. Reibel J: Prognosis of oral pre-malignant lesions: significance of clinical, histopathological and molecular biological characteristics. Crit Rev Oral Biol Med 14: 47-62, 2003.
15. Warnakulasuriya S, Reibel J, Bouquot J and Dabelsteen E: Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37: 127-133, 2008.
16. Ha PK, Benoit NE, Yochem R, et al: A transcriptional progression model for head and neck cancer. Clin Cancer Res 9: 3058-3064, 2003.
17. Ha PK, Chang SS, Glazer CA, Califano JA and Sidransky D: Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol 45: 335-339, 2009.
18. Simpson AJ, Caballero OL, Jungbluth A, Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5: 615-625, 2005.
19. Robertson KD and Wolffe AP: DNA methylation in health and disease. Nat Rev Genet 1: 11-19, 2000.
20. Ehrlich M: DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413, 2002.
21. Clark SJ and Melki J: DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 21: 5380-5387, 2002.
22. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F and Boon T: The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93: 7149-7153, 1996.
23. De Smet C, Lurquin C, Lethe B, Martelange V and Boon T: DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19: 7327-7335, 1999.
24. De Smet C, Loriot A and Boon T: Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells. Mol Cell Biol 24: 4781-4790, 2004.